自注射避孕药的数字培训:可行性和可接受性试点研究
Rhiana Mills1, Rapha Krong2, Fiona Kithinji2
1Research and Evaluation, SH:24 CIC, London, UK rhiana@sh24.org.uk.
BMJ sexual & reproductive health
|August 19, 2024
概括
通过WhatsApp视频通话进行自我注射避孕药的数字培训对于肯尼亚的参与者来说是可行的和可以接受的. 这种创新方法克服了获得基本生殖健康服务的障碍.
科学领域:
- 生殖健康 生殖健康
- 数字健康干预措施 数字健康干预措施
- 避孕技术 避孕技术的使用
背景情况:
- 自注射避孕药,比如仓库的美德基酸,提供方便,但需要初步的亲自培训.
- 这种培训可能是收养的障碍,限制了获得基本生殖健康服务的机会.
- 数字培训为克服地理和后勤挑战提供了潜在的解决方案.
研究的目的:
- 评估数字自我注射培训对避孕药的可行性和可接受性.
- 探索远程培训方法的有效性,用于注射避孕药的自我管理.
主要方法:
- 肯尼亚的一项试点研究涉及11名参与者,他们目前正在使用注射避孕药.
- 通过WhatsApp视频通话由临床医生远程提供培训,包括模拟和监督的自我注射.
- 用检查清单评估参与者的熟练程度,并通过问卷和观察收集反.
主要成果:
- 所有参与者在数字培训后都获得了自我注射的熟练程度.
- 参与者认为远程培训方法是可以接受的.
- 缺乏优质的数字设备被认为是培训的障碍.
结论:
- 通过WhatsApp视频通话进行远程培训是一种可行和可接受的方法,可以教自己注射避孕药.
- 学到的经验教训为基于数字技能的健康沟通提供了实用的见解.
- 建议进行进一步的研究,以评估数字自我注射培训的有效性和更广泛的适用性.
相关概念视频
Drug Delivery: Parenteral Route
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Bioavailability Study Design: Single Versus Multiple Dose Studies
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
Bioavailability Study Design: Healthy Subjects Versus Patients
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
Modified-Release Drug Delivery Systems: Bioavailability
Modified-release (MR) dosage forms are designed to extend drug release over time, thereby maintaining stable plasma concentrations and reducing dosing frequency. However, their bioavailability is typically below 100% due to incomplete drug release and presystemic metabolism, and limitations in drug permeability across the gastrointestinal epithelium, all of which can restrict the fraction of the drug reaching systemic circulation. Consequently, studying the in vivo bioavailability of MR...
Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices
Parenteral drug delivery systems play a crucial role in modern therapeutics by enabling the direct administration of drugs into the systemic circulation, bypassing the gastrointestinal tract. These systems are particularly valuable for poorly absorbed oral medications that are unstable in the digestive environment or require rapid onset or sustained therapeutic levels. Delivery is achieved through intravenous, intramuscular, or subcutaneous routes, each selected based on the drug's properties...
Intrauterine Drug Delivery Systems
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...


